129 related articles for article (PubMed ID: 16855392)
1. Characterization of CD44v3-containing isoforms in head and neck cancer.
Reategui EP; de Mayolo AA; Das PM; Astor FC; Singal R; Hamilton KL; Goodwin WJ; Carraway KL; Franzmann EJ
Cancer Biol Ther; 2006 Sep; 5(9):1163-8. PubMed ID: 16855392
[TBL] [Abstract][Full Text] [Related]
2. A novel CD44 v3 isoform is involved in head and neck squamous cell carcinoma progression.
Franzmann EJ; Weed DT; Civantos FJ; Goodwin WJ; Bourguignon LY
Otolaryngol Head Neck Surg; 2001 Apr; 124(4):426-32. PubMed ID: 11283501
[TBL] [Abstract][Full Text] [Related]
3. Characterization of CD44v6 isoforms in head-and-neck squamous-cell carcinoma.
van Hal NL; van Dongen GA; Stigter-van Walsum M; Snow GB; Brakenhoff RH
Int J Cancer; 1999 Sep; 82(6):837-45. PubMed ID: 10446451
[TBL] [Abstract][Full Text] [Related]
4. CD44 variant isoforms in head and neck squamous cell carcinoma progression.
Wang SJ; Wong G; de Heer AM; Xia W; Bourguignon LY
Laryngoscope; 2009 Aug; 119(8):1518-30. PubMed ID: 19507218
[TBL] [Abstract][Full Text] [Related]
5. A new CD44V3-containing isoform is involved in tumor cell growth and migration during human breast carcinoma progression.
Kalish ED; Iida N; Moffat FL; Bourguignon LY
Front Biosci; 1999 Jan; 4():A1-8. PubMed ID: 9872731
[TBL] [Abstract][Full Text] [Related]
6. Frequent expression of the high molecular, 673-bp CD44v3,v8-10 variant in colorectal adenomas and carcinomas.
Kopp R; Fichter M; Schalhorn G; Danescu J; Classen S
Int J Mol Med; 2009 Nov; 24(5):677-83. PubMed ID: 19787202
[TBL] [Abstract][Full Text] [Related]
7. Association of CD44 V3-containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neck cancer.
Wang SJ; Wreesmann VB; Bourguignon LY
Head Neck; 2007 Jun; 29(6):550-8. PubMed ID: 17252589
[TBL] [Abstract][Full Text] [Related]
8. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
[TBL] [Abstract][Full Text] [Related]
9. Salivary soluble CD44: a potential molecular marker for head and neck cancer.
Franzmann EJ; Reategui EP; Carraway KL; Hamilton KL; Weed DT; Goodwin WJ
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):735-9. PubMed ID: 15767360
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of CD44 variant expression in oral, head and neck squamous cell carcinomas using a triple approach and its clinical significance.
Athanassiou-Papaefthymiou M; Shkeir O; Kim D; Divi V; Matossian M; Owen JH; Czerwinski MJ; Papagerakis P; McHugh J; Bradford CR; Carey TE; Wolf GT; Prince ME; Papagerakis S
Int J Immunopathol Pharmacol; 2014; 27(3):337-49. PubMed ID: 25280025
[TBL] [Abstract][Full Text] [Related]
11. Distinct epigenetic profiling in head and neck squamous cell carcinoma stem cells.
Furusawa J; Zhang H; Vural E; Stone A; Fukuda S; Oridate N; Fang H; Ye Y; Suen JY; Fan CY
Otolaryngol Head Neck Surg; 2011 Jun; 144(6):900-9. PubMed ID: 21493336
[TBL] [Abstract][Full Text] [Related]
12. Collagen type XI α1 facilitates head and neck squamous cell cancer growth and invasion.
Sok JC; Lee JA; Dasari S; Joyce S; Contrucci SC; Egloff AM; Trevelline BK; Joshi R; Kumari N; Grandis JR; Thomas SM
Br J Cancer; 2013 Dec; 109(12):3049-56. PubMed ID: 24231953
[TBL] [Abstract][Full Text] [Related]
13. Colocalization of basic fibroblast growth factor and CD44 isoforms containing the variably spliced exon v3 (CD44v3) in normal skin and in epidermal skin cancers.
Grimme HU; Termeer CC; Bennett KL; Weiss JM; Schöpf E; Aruffo A; Simon JC
Br J Dermatol; 1999 Nov; 141(5):824-32. PubMed ID: 10583162
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD44v3 splice variant is associated with the visceral metastatic phenotype of human melanoma.
Döme B; Somlai B; Ladányi A; Fazekas K; Zöller M; Tímár J
Virchows Arch; 2001 Nov; 439(5):628-35. PubMed ID: 11764382
[TBL] [Abstract][Full Text] [Related]
15. CD44v3 protein-carrying tumor-derived exosomes in HNSCC patients' plasma as potential noninvasive biomarkers of disease activity.
Theodoraki MN; Matsumoto A; Beccard I; Hoffmann TK; Whiteside TL
Oncoimmunology; 2020; 9(1):1747732. PubMed ID: 32313730
[TBL] [Abstract][Full Text] [Related]
16. CD44(high) /ALDH1(high) head and neck squamous cell carcinoma cells exhibit mesenchymal characteristics and GSK3β-dependent cancer stem cell properties.
Seino S; Shigeishi H; Hashikata M; Higashikawa K; Tobiume K; Uetsuki R; Ishida Y; Sasaki K; Naruse T; Rahman MZ; Ono S; Simasue H; Ohta K; Sugiyama M; Takechi M
J Oral Pathol Med; 2016 Mar; 45(3):180-8. PubMed ID: 26399460
[TBL] [Abstract][Full Text] [Related]
17. Alternatively spliced ANLN isoforms synergistically contribute to the progression of head and neck squamous cell carcinoma.
Guo E; Mao X; Wang X; Guo L; An C; Zhang C; Song K; Wang G; Duan C; Zhang X; Yang X; Yuan Z; Sun J; Li X; Yang W; Meng H; Miao S
Cell Death Dis; 2021 Aug; 12(8):764. PubMed ID: 34344861
[TBL] [Abstract][Full Text] [Related]
18. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
Bourguignon LYW; Earle C; Shiina M
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
[TBL] [Abstract][Full Text] [Related]
19. Role of hyaluronan-mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance.
Wang SJ; Bourguignon LY
Am J Pathol; 2011 Mar; 178(3):956-63. PubMed ID: 21356346
[TBL] [Abstract][Full Text] [Related]
20. A novel splice variant of LOXL2 promotes progression of human papillomavirus-negative head and neck squamous cell carcinoma.
Liu C; Guo T; Sakai A; Ren S; Fukusumi T; Ando M; Sadat S; Saito Y; Califano JA
Cancer; 2020 Feb; 126(4):737-748. PubMed ID: 31721164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
